Keywords
MedicinePravastatinMyocardial infarctionUnstable anginaInternal medicineRandomized controlled trialAnginaCardiologyPopulationPlaceboCholesterol
Related Publications
Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: A 16-year follow-up of the Primary Prevention Study in Gateborg, Sweden
The long-term absolute risk of death in men with coronary disease and elevated serum cholesterol is very high. Implementation of lipid-lowering strategies shown to be efficaciou...
Reduction in Cardiovascular Events During Pravastatin Therapy
Background It has been documented that the HMG coenzyme A reductase inhibitors, or statins, can decrease cardiovascular events and mortality in patients with clinical coronary d...
Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris
Clinical trials have demonstrated a prophylactic role for aspirin in myocardial infarction and in unstable angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) is ...
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespec...
Publication Info
- Year
- 1995
- Type
- article
- Volume
- 76
- Issue
- 7
- Pages
- 474-479
- Citations
- 94
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
94
OpenAlex
Cite This
(1995).
Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.
The American Journal of Cardiology
, 76
(7)
, 474-479.
https://doi.org/10.1016/s0002-9149(99)80133-7
Identifiers
- DOI
- 10.1016/s0002-9149(99)80133-7